market access

News

Roche pulls cancer drug from Greece in pricing row

Roche has withdrawn a cancer drug from Greece, saying that a series of government-imposed price discounts have made it impossible to market the drug there.

Partner Content

Partner Content

Intellectual Property and Regulatory Law: Recent Development...

Intellectual Property Law

Partner Content

Partner Content

Attendee list for Biosimilars North America 2017 released

Attendee list for Biosimilars North America 2017 releas

Views & Analysis

Addressing market access obstacles 570x320

Addressing market access obstacles for rare bleeding disorde...

Scrutiniseing the market access situation for people with rare bleeding disorders.

News

NICE rejects Bayer and Eisai drugs in thyroid cancer

Thyroid cancer drugs are available in Scotland and Wales

Views & Analysis

Navigating the barriers to successful market access

The steps required for successful market access.

Roche pulls cancer drug from Greece in pricing row

Intellectual Property and Regulatory Law: Recent Development...

Attendee list for Biosimilars North America 2017 released

Addressing market access obstacles for rare bleeding disorde...

NICE rejects Bayer and Eisai drugs in thyroid cancer

Navigating the barriers to successful market access

GBL joins CVC in €10.7bn takeover bid for Recordati

Discover a new era of healthcare panel engagement: Grounded ...

market access

Editor's Picks